Abstract
The coagulating activity of Bothrops atrox venom was investigated in vitro with purified fibrinogen, with normal plasma and with plasma deficient in various factors of the coagulation cascade. This study indicated that Bothrops atrox venom possesses a thrombin-like action caused by one or several serine proteases sensitive to DFP treatment, but that its clotting action is in fact mainly due to components insensitive to DFP which activate prothrombin and factor X (Stuart factor). We partially purified the DFP insensitive activator of factor X from Bothrops atrox venom and found it to be a protein of molecular weight 77,000. Analysis of the purified fraction by electrophoresis on polyacrylamide gel in the presence of SDS showed that it is mainly composed of one heavy polypeptide chain (65,000) and one light doublet (12 - 13,000). This activator is calcium-dependent and catalyzes in vitro the conversion of purified factor X into factor X alpha. By its molecular properties, it resembles the factor X activator from Vipera russellii venom rather than physiological activators.
References
Aug 7, 1979·Biochemistry·E P KirbyT M Brudzynski
Aug 7, 1979·Biochemistry·S NiewiarowskiK Stocker
Jan 1, 1977·Toxicon : Official Journal of the International Society on Toxinology·Y Furukawa, K Hayashi
Jun 1, 1977·Thrombosis Research·S NiewiarowskiK Stocker
Nov 29, 1977·Biochemistry·R G Di ScipioE W Davie
Nov 2, 1976·Biochemistry·W KisielE W Davie
Jan 1, 1976·Methods in Enzymology·K Stocker, G H Barlow
May 1, 1964·The Biochemical Journal·P Andrews
Sep 13, 1974·Biochimica Et Biophysica Acta·B C FurieW J Williams
Mar 1, 1972·The Journal of Clinical Investigation·S NiewiarowskiJ F Mustard
Dec 19, 1972·Biochemistry·K FujikawaE W Davie
Apr 1, 1973·The Biochemical Journal·M W Hatton
Nov 12, 1971·Biochimica Et Biophysica Acta·C M JacksonD J Hanahan
Aug 15, 1970·Nature·U K Laemmli
May 1, 1970·Toxicon : Official Journal of the International Society on Toxinology·K W Denson, W E Rousseau
Apr 1, 1969·Biochemistry·S SchiffmanS I Rapaport
Oct 1, 1969·The American Journal of Medicine·H J WeissS Kochwa
Jul 1, 1967·British Journal of Haematology·M P Esnouf, G W Tunnah
Jan 5, 1982·Biochemistry·G W AmphlettF J Castellino
Feb 1, 1983·Journal of Neurochemistry·Z Y Li, C Bon
Jul 1, 1962·The Biochemical Journal·W J WILLIAMS, M P ESNOUF
Oct 1, 1961·British Journal of Haematology·R G MACFARLANE
Apr 30, 1937·The Journal of Experimental Medicine·H Eagle
Mar 20, 1937·The Journal of General Physiology·H Eagle, T N Harris
Citations
Jan 1, 1989·Toxicon : Official Journal of the International Society on Toxinology·F ChavesL Cerdas
Jan 1, 1989·Toxicon : Official Journal of the International Society on Toxinology·J A GenéL Cerdas
Jan 1, 1989·Toxicon : Official Journal of the International Society on Toxinology·A S Kamiguti, J L Cardoso
Aug 1, 1993·Toxicon : Official Journal of the International Society on Toxinology·T FaridM F el-Asmar
Jan 1, 1995·Toxicon : Official Journal of the International Society on Toxinology·M Samel, J Siigur
Jan 1, 1986·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·J M GutiérrezL Cerdas
Oct 12, 2000·Toxicon : Official Journal of the International Society on Toxinology·S Y ChoY S Kim
Oct 12, 2000·Toxicon : Official Journal of the International Society on Toxinology·Y S KohD S Kim
Aug 30, 2000·Thrombosis Research·Y KohD Kim
Aug 2, 2003·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Mari SamelJüri Siigur
Jul 25, 2000·British Journal of Pharmacology·C C WuC M Teng
Jun 5, 2007·FEBS Letters·Junyun HeJun Gu
Oct 22, 2013·Toxicon : Official Journal of the International Society on Toxinology·Liliane Maria Fernandes de OliveiraRaghuvir K Arni
Feb 5, 2014·Biochemical and Biophysical Research Communications·Peng GengWenli Li
Feb 10, 1987·Biochemistry·H Hofmann, C Bon
Feb 10, 1987·Biochemistry·H Hofmann, C Bon
Oct 12, 1993·Biochemistry·R B ZingaliC Bon
Oct 14, 2018·Toxins·Leijiane F SousaBryan G Fry
Nov 30, 2005·European Journal of Pharmacology·Chin-Chung WuYang-Chang Wu